Abstract:The ocular surface is the outermost part of the visual system that faces many extrinsic or intrinsic threats, such as chemical burn, infectious pathogens, thermal injury, Stevens-Johnson syndrome, ocular pemphegoid, and other autoimmune diseases. The cornea plays an important role in conducting light into the eyes and protecting intraocular structures. Several ocular surface diseases will lead to the neovascularization or conjunctivalization of corneal epithelium, leaving opacified optical media. It is believed that some corneal limbal cells may present stem cell-like properties and are capable of regenerating corneal epithelium. Therefore, cultivation of limbal cells and reconstruction of the ocular surface with these limbal cell grafts have attracted tremendous interest in the past few years. Currently, stem cells are found to potentiate regenerative medicine by their capability of differentiation into multiple lineage cells. Among these, the most common cell sources for clinical use are embryonic, adult, and induced stem cells. Different stem cells have varied specific advantages and limitations for in vivo and in vitro expansion. Other than ocular surface diseases, culture and transplantation of corneal endothelial cells is another major issue for corneal decompensation and awaits further studies to find out comprehensive solutions dealing with nonregenerative corneal endothelium. Recently, studies of in vitro endothelium culture and ρ-associated kinase (ROCK) inhibitor have gained encouraging results. Some clinical trials have already been finished and achieved remarkable vision recovery. Finally, nanotechnology has shown great improvement in ocular drug delivery systems during the past two decades. Strategies to reconstruct the ocular surface could combine with nanoparticles to facilitate wound healing, drug delivery, and even neovascularization inhibition. In this review article, we summarized the major advances of corneal limbal stem cells, limbal stem cell deficiency, corneal endothelial cell culture/transplantation, and application of nanotechnology on ocular surface reconstruction. We also illustrated potential applications of current knowledge for the future treatment of ocular surface diseases.

Stem cell and lens regeneration

Lens Regeneration: Scientific Discoveries and Clinical Possibilities

Lens Regeneration in Situ Using Hescs-Derived Cells —similar to Natural Lens

Lens regeneration using endogenous stem cells with gain of visual function

Reprogramming of Ipscs to NPCEC-like Cells by Biomimetic Scaffolds for Zonular Fiber Reconstruction

Generation of Functional Lentoid Bodies from Human Induced Pluripotent Stem Cells Derived from Urinary Cells.

Efficient Generation of Lens Progenitor Cells from Cataract Patient-Specific Induced Pluripotent Stem Cells

3D Bioprinting As a Prospective Therapeutic Strategy for Corneal Limbal Epithelial Stem Cell Deficiency

Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges

Biologicals and Biomaterials for Corneal Regeneration and Vision Restoration in Limbal Stem Cell Deficiency

Eye lens organoids going simple: characterization of a new 3-dimensional organoid model for lens development and pathology

Eye Lens Organoids Made Simple: Characterization of a New Three-Dimensional Organoid Model for Lens Development and Pathology

Adult stem cells in the eye: Identification, characterisation, and therapeutic application in ocular regeneration – A review

Use of Human Pluripotent Stem Cells to Define Initiating Molecular Mechanisms of Cataract for Anti-Cataract Drug Discovery

Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders

Advances in Cell Transplantation Therapy for Limbal Stem Cell Deficiency.

Modeling Congenital Cataract in Vitro Using Patient-Specific Induced Pluripotent Stem Cells

Generation of Functional Lentoid Bodies from Human-Induced Pluripotent Stem Cells

Regenerative Mechanisms of Stem Cells and Their Clinical Applications for Degenerative Eye Diseases

Generation of Human Lens Epithelial‐Like Cells from Patient‐Specific Induced Pluripotent Stem Cells

Development of a potent embryonic chick lens model for studying congenital cataracts in vivo